Unio Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Unio Capital's GILD Position: Q2 2022 in Review
Unio Capital sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 135,823 shares — an estimated $8.07M sold.
Unio Capital first reported a position in GILD in Q4 2017 and held it in 18 quarters. The position peaked at $9.19M in Q3 2021. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.
- Unio Capital reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
- Unio Capital sold 135,823 Gilead Sciences shares in Q2 2022, an estimated $8.07M.
- Unio Capital first reported a position in Gilead Sciences in Q4 2017 and held it in 18 quarters.
- Unio Capital's Gilead Sciences position peaked at $9.19M in Q3 2021.
- 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.
Based on Unio Capital's 13F filing for Q2 2022, filed 15 Aug 2022.